(firstQuint)Study Comparing Test to Aczone 5% and Both to a Placebo Control in the Treatment of Acne Vulgaris.

 To evaluate the therapeutic equivalence and safety of Test formulation and marketed Reference Listed Drug (RLD).

 To demonstrate the superiority of efficacy of the Test and Reference products over the placebo control in the treatment.

 To compare the safety of Test, Reference and Placebo treatments.

.

 Study Comparing Test to Aczone 5% and Both to a Placebo Control in the Treatment of Acne Vulgaris@highlight

Therapeutic equivalence and safety study